About Aurio Pharma Laboratories
Aurio Pharma Laboratories is a Healthcare company based in Kolkata (India) by Ramlal Bhattacharejee. It manufactures and markets pharmaceutical drugs, including syrups and tablets, in Eastern India. It operates on a B2B and B2C model. The company has 114 employees. Its Indian entity Aurio Pharma Laboratories Private Limited reported revenue of ₹27.02 Cr. Aurio Pharma Laboratories offers products and services including Gassanol, HEMATON, AURIOZYME, HEPCAR, and Zevital Syrup. Its focus areas include Pharmaceuticals, Manufacturing, Drug Production and Marketing. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Aurio Pharma Laboratories, established in 1972 in Kolkata, India, produces a variety of pharmaceutical products such as syrups, tablets, and therapy packs. The company operates through manufacturing units equipped for over 200 product varieties, including antibiotics and vitamins. It markets these via a network of over 200 executives reaching 15,000 doctors and 50,000 retailers. Serving government agencies and consumers, it focuses on quality, innovation, and customer satisfaction in healthcare.
- Headquarters Kolkata, India
- Employees 114
- Founders Ramlal Bhattacharejee
- SectorsHealthcare
- Email••••••••
- Website auriopharma.com
- Social X Facebook Instagram YouTube
- Legal Name Aurio Pharma Laboratories Private Limited
- Date of Incorporation 30 Mar, 1998
- Jurisdiction Kolkata, West Bengal, India
- Annual Revenue₹27.02 Cr
FY 2025 · -9% YoY
- Net Profit₹26.6 Lakh
FY 2025 · 1% margin
- EBITDA₹1.08 Cr
FY 2025 · 4% margin
- Employee Count114
Associated legal entities of Aurio Pharma Laboratories
Aurio Pharma Laboratories operates through Aurio Pharma Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aurio Pharma Laboratories Private Limited CIN U85195WB1998PTC086879 | Active | 30 Mar 1998 | Kolkata, West Bengal | ₹27.0 Cr | 114 | 2 | View details |
Products & Services of Aurio Pharma Laboratories
Aurio Pharma Laboratories offers a comprehensive portfolio of products and services, including Gassanol, HEMATON, AURIOZYME, HEPCAR, and Zevital Syrup.
Pack for stomach therapy and relief from digestive issues.
Syrup addressing iron deficiency and related health concerns.
Product for improving digestion and enzyme support.
Syrup for liver health and related functions.
Syrup providing vitamins and nutritional benefits.
Apps and channels of Aurio Pharma Laboratories
its YouTube channel Aurio Pharma has 261 subscribers and 19 videos.
Videos from Aurio Pharma Laboratories
The most watched videos on Aurio Pharma Laboratories's YouTube channel, Aurio Pharma (261 subscribers). Click a video to play it here.
More on Aurio Pharma.
Board of directors of Aurio Pharma Laboratories Private Limited (Aurio Pharma Laboratories)
Aurio Pharma Laboratories Private Limited is the primary company behind Aurio Pharma Laboratories. The board of Aurio Pharma Laboratories Private Limited currently have 2 directors; the longest-serving is Santosh Bhattacharya, appointed in 1998. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Santosh Bhattacharya DIN 00296257 | Director | 30 Mar 1998 | 28 yrs 6 mo | Aurio Pharma Laboratories Private Limited |
| Mandira Bhattacharjee DIN 00684193 | Director | 18 Aug 1999 | 27 yrs 2 mo | Aurio Pharma Laboratories Private Limited |
People of Aurio Pharma Laboratories
1 people are tracked at Aurio Pharma Laboratories (1 in leadership); the tracked headcount is 114.
| Name | Role | Group |
|---|---|---|
Ramlal Bhattacharejee | Founder | Leadership |
Complete people profiles for Aurio Pharma Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Aurio Pharma Laboratories
Figures of Aurio Pharma Laboratories Private Limited, the primary company behind Aurio Pharma Laboratories, for FY 2025. Revenue was ₹27.02 Cr (-9% year on year). Net profit was ₹26.6 Lakh (1% margin). EBITDA was ₹1.08 Cr (4% margin). Revenue has grown at a compounded annual rate of +17% over three years and +2% over five years.
- ₹27.02 CrRevenue · FY 2025 · -9% YoY
- ₹26.6 LakhNet profit · 1% margin
- ₹1.08 CrEBITDA · 4% margin
- ₹16.8 LakhPaid-up capital
- 114Employees (provident fund records)
- +17%Revenue CAGR, 3 years
- +2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aurio Pharma Laboratories Private Limited are on its company page.
Detailed financial statements for Aurio Pharma Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Aurio Pharma Laboratories
Aurio Pharma Laboratories has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Aurio Pharma Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aurio Pharma Laboratories
The website of Aurio Pharma Laboratories (auriopharma.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▼ 57.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aurio Pharma Laboratories
Aurio Pharma Laboratories is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.
Aurio Pharma Laboratories has 114 employees.
The primary company behind Aurio Pharma Laboratories, Aurio Pharma Laboratories Private Limited, reported revenue of ₹27.02 Cr for FY 2025, down 9% year on year.
Aurio Pharma Laboratories, established in 1972 in Kolkata, India, produces a variety of pharmaceutical products such as syrups, tablets, and therapy packs. The company operates through manufacturing units equipped for over 200 product varieties, including antibiotics and vitamins. It markets these via a network of over 200 executives reaching 15,000 doctors and 50,000 retailers. Serving government agencies and consumers, it focuses on quality, innovation, and customer satisfaction in healthcare.
Aurio Pharma Laboratories's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Aurio Pharma Laboratories offers Gassanol, HEMATON, AURIOZYME, HEPCAR, and Zevital Syrup.
Aurio Pharma Laboratories operates through Aurio Pharma Laboratories Private Limited.
The legal entities of Aurio Pharma Laboratories currently have 2 directors, including Santosh Bhattacharya, Mandira Bhattacharjee.